Search by Drug Name or NDC

    NDC 00074-3399-30 Norvir 100 mg/1 Details

    Norvir 100 mg/1

    Norvir is a ORAL POWDER in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is RITONAVIR.

    Product Information

    NDC 00074-3399
    Product ID 0074-3399_4fac307e-e822-429d-9516-d95e86529dc9
    Associated GPIs 12104560003020
    GCN Sequence Number 075279
    GCN Sequence Number Description ritonavir POWD PACK 100 MG ORAL
    HIC3 W5C
    HIC3 Description ANTIVIRALS, HIV-SPECIFIC, PROTEASE INHIBITORS
    GCN 40309
    HICL Sequence Number 010412
    HICL Sequence Number Description RITONAVIR
    Brand/Generic Brand
    Proprietary Name Norvir
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ritonavir
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name RITONAVIR
    Labeler Name AbbVie Inc.
    Pharmaceutical Class Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A In
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209512
    Listing Certified Through 2024-12-31

    Package

    NDC 00074-3399-30 (00074339930)

    NDC Package Code 0074-3399-30
    Billing NDC 00074339930
    Package 30 PACKET in 1 CARTON (0074-3399-30) / 1 POWDER in 1 PACKET
    Marketing Start Date 2017-06-07
    NDC Exclude Flag N
    Pricing Information N/A